EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Trends in the proportion of patients younger than 75 years with acute myocardial infarction and Killip class III and IV. variables associated with occurence and case-fatality: 1978-1997



Trends in the proportion of patients younger than 75 years with acute myocardial infarction and Killip class III and IV. variables associated with occurence and case-fatality: 1978-1997



Revista Espanola de Cardiologia 55(11): 1117-1123



Acute pulmonary edema (Killip III) or cardiogenic shock (Killip IV) is associated with a higher mortality in the acute phase of myocardial infarction (AMI). To analyze trends in the proportion of patients who developed Killip III and IV in AMI over a 20-year period in order to identify the variables associated with occurrence and case-fatality. Hospital registry of first AMI in patients under than 75 years, from 1978 to 1997. Sociodemographic variables, cardiovascular risk factors, clinical variables, treatments, procedures, and worst Killip class were recorded. The registry included 2,590 patients. Mean age was 60 years and 17% were women. Thirteen percent (13.5%) of the patients developed Killip III and IV, and no changes in this proportion were observed over the time period studied. Age, diabetes, previous angina, and anterior location of AMI were associated with a higher risk of Killip III and IV. Case-fatality at 28 days in this subgroup was 51.7%, with a decreasing linear trend over the years. Variables associated with a higher case-fatality were age and malignant ventricular arrhythmias, whereas the periods 1990-93 and 1994-97 were associated with a lower case-fatality. This protective effect disappeared after adjusting for treatment variables (antiplatelet agents and thrombolysis). The proportion of patients with AMI in which Killip class III and IV develops has remained stable in the last two decades. Although the 28-day case-fatality in these patients is high, a decrease has been observed in recent years in relation to the availability of new treatments (antiplatelet agents and thrombolysis).

(PDF emailed within 1 workday: $29.90)

Accession: 047841297

Download citation: RISBibTeXText

PMID: 12423567



Related references

Trends in proportion of patients in Killip class III and IV in myocardial infarction Variables associated with it and with mortality. European Heart Journal 23(Abstract Supplement): 194, August-September, 2002

Trends in Q-wave acute myocardial infarction case fatality from 1978 to 2007 and analysis of the effectiveness of different treatments. American Heart Journal 162(3): 444-450, 2011

Predictors of non-invasive therapy and 28-day-case fatality in elderly compared to younger patients with acute myocardial infarction: an observational study from the MONICA/KORA Myocardial Infarction Registry. Bmc Cardiovascular Disorders 16(): 151-151, 2016

Case-fatality trends in 117,718 patients admitted to hospital with a first acute myocardial infarction. Circulation 102(18 Supplement): II 867, October 31, 2000

Trends in case-fatality in 117 718 patients admitted with acute myocardial infarction in Scotland. European Heart Journal 21(22): 1833-1840, 2000

APACHE-II score and Killip class for patients with acute myocardial infarction. Intensive Care Medicine 36(9): 1579-1586, 2010

Time trends of acute myocardial infarction morbidity, mortality, 28-day-case-fatality and acute medical care: Results of the Augsburg myocardial infarction register from 1985-1992. Zeitschrift fuer Kardiologie 84(8): 596-605, 1995

Improved survival after acute myocardial infarction in patients with advanced Killip class. Clinical Cardiology 23(10): 751-758, October, 2000

Trends in 30-day case fatality rate in patients hospitalized due to acute myocardial infarction in Beijing, 2007-2012. Zhonghua Liu Xing Bing Xue Za Zhi 39(3): 363-367, 2018

Are the data on trends in case-fatality in patients with acute myocardial infarction observed in Scotland applicable across Europe?. European Heart Journal 22(12): 979-980, 2001

Relationship of therapeutic improvements and 28-day case fatality in patients hospitalized with acute myocardial infarction between 1978 and 1993 in the REGICOR study, Gerona, Spain. Circulation 99(13): 1767-1773, April 6, 1999

Outcomes of patients with Killip class III acute myocardial infarction after primary percutaneous coronary intervention. Critical Care Medicine 39(3): 436-442, 2011

In-hospital development of cardiogenic shock among acute myocardial infarction patients admitted in Killip class I. Circulation 86(4 SUPPL 1): I403, 1992

Extent of the decrease of 28-day case fatality of hospitalized patients with acute myocardial infarction over 22 years: epidemiological versus clinical view: the MONICA/KORA Augsburg infarction registry. Circulation. Cardiovascular Quality and Outcomes 2(4): 313-319, 2010

Influence of thrombolysis and antiplatelet drugs on myocardial infarction patient 28-day case-fatality trends from 1978 to 1993 in Gerona, Spain. Journal of the American College of Cardiology 31(2 SUPPL A): 490A, 1998